Influence of Menopausal Hormone Therapy on Body Composition and Metabolic Parameters
نویسندگان
چکیده
منابع مشابه
Changes in body composition during post-menopausal hormone therapy: a 2 year prospective study.
BACKGROUND Post-menopausal hormone therapy (pHT) induces changes in both body composition and bone mineral density (BMD). METHODS In 109 post-menopausal women beginning either tibolone 2.5 mg (n=29), tibolone 1.25 mg (n=42) or estradiol 2 mg plus norethisterone acetate 1 mg (E2 + NETA) (n=38), we assessed body composition, total and regional BMD by dual energy X-ray absorptiometry, and the se...
متن کاملeffect of tibolone and hormone therapy on body composition and fat distribution in postmenopausal women
background: menopause is associated with changes in body composition in postmenopausal women. the aim of this study was to compare the effects of tibolone and continuous combined hormone therapy (ht) on body composition in postmenopausal women. materials and methods: in this randomized clinical trial, 120 menopausal women were randomly selected and divided into three groups. of these, 40 women ...
متن کاملGlobal Consensus Statement on menopausal hormone therapy.
The following Consensus Statement is endorsed by The American Society for Reproductive Medicine, The Asia Pacific Menopause Federation, The Endocrine Society, The European Menopause and Andropause Society, The International Menopause Society, The International Osteoporosis Foundation and The North American Menopause Society.
متن کاملProgestogens in menopausal hormone therapy
Progestogens share one common effect: the ability to convert proliferative endometrium to its secretory form. In contrast, their biological activity is varied, depending on the chemical structure, pharmacokinetics, receptor affinity and different potency of action. Progestogens are widely used in the treatment of menstrual cycle disturbances, various gynaecological conditions, contraception and...
متن کاملCompounded bioidentical menopausal hormone therapy
Although improvement in long-term health is no longer an indication for menopausal hormone therapy, evidence supporting fewer adverse events in younger women, combined with its high overall effectiveness, has reinforced its usefulness for short-term treatment of menopausal symptoms. Menopausal therapy has been provided not only by commercially available products but also by compounding, or crea...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: BioResearch Open Access
سال: 2020
ISSN: 2164-7860
DOI: 10.1089/biores.2019.0050